Experts across healthcare debunk 15 common myths about GLP-1 medications—covering everything from access and cost to ...

As I wrote in my last note on Structure: The most famous examples of GLP-1 agonist drugs are Novo Nordisk's (NVO) semaglutide - approved to treat Type 2 Diabetes ("T2D") under the brand name ...

Ozempic and similar semaglutide-based medications have been hailed as miracle drugs. Known as GLP-1 (glucagon-like peptide-1) agonists, this class of medications mimics a natural hormone the small ...

Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists ... The treatments, which include medications like semaglutide, liraglutide and exenatide, have been ...

Tirzepatide is approved by the Food and Drug Administration (FDA) for treating type 2 diabetes and obesity, akin to other GLP-1 medications such as semaglutide. The days of cheaper versions of ...

"Considerable attention has been given to the rapid rise in GLP-1 receptor agonist use since semaglutide's [Ozempic, Wegovy] approval for chronic weight management in 2021," he added. "Given this ...

GLP-1RAs include semaglutide, the active ingredient in Ozempic (approved for type 2 diabetes) and Wegovy (approved for weight management). These medications mimic the hormone GLP-1, which helps ...

People taking an oral formulation of the glucagon-like peptide-1 (GLP-1) agonist semaglutide were 14% less likely than those taking a placebo to experience cardiovascular death, heart attack or ...

The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of suicidality as previously suggested, an analysis of UK data has found. A ...